Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Analysis of Dabrafenib +/- Trametinib Compassionate Use Experience in Spain

NCT02439411 is registered in ClinicalTrials.gov with Grupo Español Multidisciplinar de Melanoma as lead sponsor.

NCT NCT02439411
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02439411 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Analysis of Dabrafenib +/- Trametinib Compassionate Use Experience in Spain
Lead sponsor
Grupo Español Multidisciplinar de Melanoma
Phase
Observational
Overall status
Completed
Start date
March 3, 2015
Completion date
September 30, 2016
Enrollment
135 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

malignant melanoma stage iiic, malignant melanoma stage iv